The influence of elevated hormone levels on physiologic accumulation of 68Ga-DOTATOC

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Annals of Nuclear Medicine

• Publication date

  2018-01-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12149-018-1233-4PMID 29349562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 60 YEARS OF POMC: Adrenal and extra-adrenal functions of ACTH.

  2016cited by this paper
• Estrogen-dependent up-regulation of TRPA1 and TRPV1 receptor proteins in the rat endometrium.

  2016cited by this paper
• Comparison of diagnostic accuracy of 111In-pentetreotide SPECT and 68Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours

  2016cited by this paper
• Additional information gained by positron emission tomography with 68Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors

  2015cited by this paper
• Diagnosis of functioning pancreaticoduodenal neuroendocrine tumors

  2015cited by this paper
• Somatostatin system: molecular mechanisms regulating anterior pituitary hormones.

  2014cited by this paper
• p38 MAPK regulates steroidogenesis through transcriptional repression of STAR gene.

  2014cited by this paper
• 68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT

  2013cited by this paper
• Diagnostic performance of somatostatin receptor PET/CT using 68Ga-DOTANOC in gastrinoma patients with negative or equivocal CT findings

  2013cited by this paper
• Normal Uptake of 68Ga-DOTA-TOC by the Pancreas Uncinate Process Mimicking Malignancy at Somatostatin Receptor PET

  2012cited by this paper
• Radiopeptide Imaging and Therapy in Europe

  2011cited by this paper
• Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours?

  2011cited by this paper
• 68Ga-DOTATOC PET/CT and somatostatin receptor (sst1–sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax

  2011cited by this paper
• Molecular imaging with 68Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours

  2011cited by this paper
• Prognostic value of total lesion glycolysis on FDG PET in diffuse large B-cell lymphoma

  2011cited by this paper
• Role of Somatostatin Receptors in Normal and Tumoral Pituitary Corticotropic Cells

  2010cited by this paper
• Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT

  2008cited by this paper
• Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells.

  2005cited by this paper
• Role of Glucocorticoids in the Regulation of Pituitary Somatostatin Receptor Subtype (sst1–sst5) mRNA Levels: Evidence for Direct and Somatostatin-Mediated Effects

  2003cited by this paper
• Regulation of mouse somatostatin receptor type 2 gene expression by glucocorticoids

  1999cited by this paper
• Alternative promoter usage and tissue specific expression of the mouse somatostatin receptor 2 gene

  1998cited by this paper
• Dexamethasone regulates somatostatin receptor subtype messenger ribonucleic acid expression in rat pituitary GH4C1 cells.

  1995cited by this paper

• [68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time?

  2022cites this paper
• An appreciation from the out-going editor-in-chief

  2019cites this paper
• Activities for the Development of Targeted Radionuclide Therapy in Japan

  2018cites this paper